Adrenocortical carcinoma is a rare disease. We report here a case of huge adrenocortical carcinoma. The aim of this study is to show the presence of this pathology in Madagascar despite its rarity, and the different steps undertaken for its diagnosis, treatment and evolution. A huge right adrenocortical carcinoma was incidentally diagnosed in a 42 year old man by ultrasonography and confirmed by computed tomography. The right adrenalectomy followed by an Op'DDD treatment gives good results in a short term. This case gave us the evidence of the usefulness of ultrasonography as a first intention investigation and the computed tomography as the only way to confirm the diagnosis. However, we can only rely on the histological findings even if the borderline between benignity and malignity is sometimes debatable. Open adrenalectomy is the main treatment, completed with an Op'DDD therapy whose efficiency is doubtful. The evolution is uncertain and the prognosis is poor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-4401(02)00010-4DOI Listing

Publication Analysis

Top Keywords

adrenocortical carcinoma
12
huge adrenocortical
8
computed tomography
8
case giant
4
giant malignant
4
adrenocortical
4
malignant adrenocortical
4
adrenocortical carcinoma]
4
carcinoma] adrenocortical
4
carcinoma rare
4

Similar Publications

The aim of this study was to evaluate the clinical benefits and outcomes of adjuvant radiation therapy on adrenocortical carcinoma (ACC) patients. All patients with ACC that were reported between 2010 and 2015 were identified from the Surveillance, Epidemiology, and End Results database. A forward-stepwise Cox proportional hazards regression was used to identify independent risk factors.

View Article and Find Full Text PDF

Necrosis in postoperative histology has been reported as being specific for adrenocortical carcinoma (ACC) compared to adenoma. We therefore retrospectively analyzed the diagnostic accuracy of the finding of necrosis in preoperative cross-sectional imaging and postoperative histology as a marker for ACC in our patient cohort. Among the 411 adrenalectomies in 396 patients performed between 2008 and April 2022, 30 cases of ACC (7.

View Article and Find Full Text PDF

Purpose: Adrenocortical carcinoma (ACC) is a rare, aggressive pediatric malignancy. Advanced ACC requires multimodal treatment, including surgery and systemic chemotherapy including cisplatin, etoposide, doxorubicin, and mitotane. This is associated with significant gastrointestinal toxicity, resulting in many patients being unable to complete scheduled therapy.

View Article and Find Full Text PDF

Adrenocortical carcinomas are rare but aggressive tumors that are frequently discovered as incidentalomas. Secretory tumors often lead to endocrine abnormalities, namely cushingoid features, virilization, or feminization. Non-functioning tumors, on the other hand, can be completely dormant with an insidious course or cause malaise, weight loss, abdominal pain, etc.

View Article and Find Full Text PDF

Background: It was controversial to use open surgery or minimally invasive surgery (MIS) for adrenocortical carcinoma (ACC). This retrospective study aimed to evaluate the impact on prognosis between MIS and open surgery in patients with clinical stage I-II ACC.

Methods: Patients with stage I-II ACC from December 2000 to October 2022 were retrospectively studied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!